Clinical Trials Logo

Spermatic Cord Block clinical trials

View clinical trials related to Spermatic Cord Block.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04498351 Completed - Clinical trials for Spermatic Cord Block

Magnesium Sulfate in Combination With Dexmedetomidine As Adjuvants to Levobupivacaine

Start date: June 30, 2020
Phase: Early Phase 1
Study type: Interventional

Using the spermatic cord block has been of great advantage, as it has been cost saving, efficient technique whether used inon its own or combination with a sedative or . Furthermore, it provides minimal cardiac risks, early case ambulation, satisfactory postoperative pain control, as well as a reduced hospital stay and cost. one of the major drawbacks of spermatic cord block is being a single injection technique, leading to a short postoperative analgesia duration. So, to overcome this flaw some adjuvants were proven to prolong the analgesia duration as Dexmetedomidine (Dex), and magnesium.

NCT ID: NCT04492319 Completed - Clinical trials for Spermatic Cord Block

Addition of Neostigmine to Levobupivacaine

Start date: September 29, 2020
Phase: N/A
Study type: Interventional

Using the spermatic cord block has been of great advantage, as it has been cost saving, efficient technique whether used inon its own or combination with a sedative or . Furthermore, it provides minimal cardiac risks, early case ambulation, satisfactory postoperative pain control, as well as a reduced hospital stay and cost. one of the major drawbacks of spermatic cord block is being a single injection technique, leading to a short postoperative analgesia duration. So, to overcome this flaw some adjuvants were proven to prolong the analgesia duration as neostigmine.